What is Zions Bancorpora's earnings per share (EPS)?

Zions Bancorpora (ZIONP) reported diluted earnings per share of $6.01 for fiscal year 2025. This represents a 21.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Zions Bancorpora (ZIONP) Financials

ZIONP

Trailing 12 months to June 30, 2026

Revenue $3.7B +15.2% YoY

Net Income $1.2B +38.7% YoY

EPS (Diluted) $7.85 +43.5% YoY

Free Cash Flow $1.7B +160.5% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ZIONP SEC filings page.

Zions Bancorpora (ZIONP) reported $3.7B in revenue over the twelve months to Jun 30, 2026, up 15.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ZIONP FY2025 2026-09-05

A balance-sheet-heavy bank converts modest asset returns into earnings while capital rebuilds and leverage rises from a low base.

Between FY2023 and FY2025, net margin widened while return on assets recovered, even as total assets stayed near $88B; earnings improved without balance-sheet growth. Operating cash flow remained above free cash flow in both years, with FY2025 at $1.1B versus $952M, showing that investment absorbs part of internally generated cash rather than accounting profit simply failing to convert.

The bank’s scale makes ROA the more revealing efficiency measure: 1.0% in FY2025 is above FY2023’s 0.8%. It remains below FY2021’s 1.2%, so the earnings rebound has not fully restored historical asset productivity.

The balance sheet is rebuilding while leverage becomes more prominent: debt-to-equity rose from 0.10x in FY2023 to 0.21x in FY2025. Equity nevertheless expanded from $5.7B to $7.2B, pointing to added funding intensity rather than erosion of book capital.

Financial Health Signals

Financial Health Score 35/100

Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Zions Bancorpora's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings

Zions Bancorpora earned a return on assets of 1.0% in fiscal year 2025, which is the profit it made on every dollar of assets on its books. This is up from 0.9% the prior year. Earnings ranks banks on that return over three years, and Zions Bancorpora scores 55/100 among other banks.

Growth

Zions Bancorpora reported revenue of $3.4B in fiscal year 2025, against $3.1B in fiscal year 2024. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and Zions Bancorpora scores 33/100 among other banks.

Capital

Zions Bancorpora funded 8.1% of its assets with shareholders' equity at the end of fiscal year 2025, holding $7.2B of equity against $88.7B of assets. Capital ranks banks on that cushion, and Zions Bancorpora scores 9/100 among other banks.

Efficiency

Efficiency measures what a bank spends running itself against the revenue that spending brings in, so a lower ratio is the better one. Zions Bancorpora scores 48/100 on it among other banks.

Credit Quality

Not available for Zions Bancorpora, and counted as zero in the overall score.

Stability

Zions Bancorpora reported net income of $899.0M in fiscal year 2025, against $784.0M in fiscal year 2024. Stability ranks banks on how steady net income has been across five years, and Zions Bancorpora scores 67/100 among other banks.

Piotroski F-Score Partial

6/7

Zions Bancorpora passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.19x

For every $1 of reported earnings, Zions Bancorpora generates $1.19 in operating cash flow ($1.1B OCF vs $899.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.1B

YoY+35.7%

QoQ+33.9%

5Y CAGR+8.4%

10Y CAGR+6.8%

Zions Bancorpora generated $1.1B in revenue in Q2 2026. This represents an increase of 35.7% from the same quarter a year earlier. Against the prior quarter it is up 33.9%.

Net Income

$453.0M

YoY+85.7%

QoQ+94.4%

5Y CAGR+5.1%

10Y CAGR+14.8%

Zions Bancorpora reported $453.0M in net income in Q2 2026. This represents an increase of 85.7% from the same quarter a year earlier. Against the prior quarter it is up 94.4%.

EPS (Diluted)

$3.05

YoY+87.1%

QoQ+95.5%

5Y CAGR+8.0%

10Y CAGR+21.4%

Zions Bancorpora earned $3.05 per diluted share (EPS) in Q2 2026. This represents an increase of 87.1% from the same quarter a year earlier. Against the prior quarter it is up 95.5%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$389.0M

YoY+518.3%

QoQ-2.3%

Zions Bancorpora generated $389.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 518.3% from the same quarter a year earlier. Against the prior quarter it is down 2.3%.

Cash & Debt

$793.0M

YoY+1.7%

QoQ+20.0%

5Y CAGR+8.6%

Zions Bancorpora held $793.0M in cash against $2.0B in long-term debt as of Q2 2026.

Dividends Per Share

$0.45

YoY+4.7%

QoQ0.0%

5Y CAGR+5.8%

Zions Bancorpora paid $0.45 per share in dividends in Q2 2026. This represents an increase of 4.7% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

146M

YoY-1.1%

QoQ-0.8%

5Y CAGR-2.1%

10Y CAGR-3.3%

Zions Bancorpora had 146M shares outstanding in Q2 2026. This represents a decrease of 1.1% from the same quarter a year earlier. Against the prior quarter it is down 0.8%.

Margins & Returns

Net Margin

39.8%

YoY+10.7pp

QoQ+12.4pp

5Y CAGR-6.7pp

10Y CAGR+20.5pp

Zions Bancorpora's net profit margin was 39.8% in Q2 2026, showing the share of revenue converted to profit. This is up 10.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 12.4 percentage points.

Return on Equity

5.9%

YoY+2.2pp

QoQ+2.7pp

5Y CAGR+1.5pp

10Y CAGR+4.4pp

Zions Bancorpora's ROE was 5.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 2.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.7 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$75.0M

QoQ-2.6%

5Y CAGR-5.8%

10Y CAGR+31.1%

Zions Bancorpora spent $75.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is down 2.6%.

Capital Expenditures

$33.0M

YoY+6.5%

QoQ+32.0%

5Y CAGR+1.3%

10Y CAGR-4.4%

Zions Bancorpora invested $33.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 6.5% from the same quarter a year earlier. Against the prior quarter it is up 32.0%.

R&D Spending

Not reported for Q2 2026.

ZIONP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ZIONP quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$3.7B	$3.4B+8.1%	$3.1B+0.5%	$3.1B-1.2%	$3.2B+8.3%	$2.9B+4.3%	$2.8B-1.7%	$2.8B+2.0%	$2.8B+6.7%	$2.6B+9.5%	$2.4B+15.0%	$2.1B-4.6%	$2.2B+6.8%	$2.0B-5.5%	$2.2B-4.5%	$2.3B
SG&A Expenses	$1.6B	$1.4B+4.9%	$1.3B+0.9%	$1.3B+3.2%	$1.2B+9.6%	$1.1B+3.7%	$1.1B-4.7%	$1.1B+6.6%	$1.1B+6.4%	$1.0B+2.9%	$978.0M+0.5%	$973.0M+1.7%	$956.4M+4.8%	$912.9M+3.1%	$885.7M+1.3%	$874.3M
Interest Expense	$1.8B	$1.6B-16.4%	$1.9B+23.5%	$1.5B+715.7%	$185.0M+213.6%	$59.0M-61.2%	$152.0M-63.0%	$411.0M+63.7%	$251.0M+97.6%	$127.0M+46.0%	$87.0M-26.3%	$118.0M-31.8%	$173.0M-29.4%	$245.1M-20.1%	$306.8M-29.1%	$432.4M
Income Tax	N/A	$276.0M+21.1%	$228.0M+10.7%	$206.0M-15.9%	$245.0M-22.7%	$317.0M+138.3%	$133.0M-43.9%	$237.0M-8.5%	$259.0M-24.7%	$344.0M+45.8%	$236.0M+66.2%	$142.0M-36.3%	$223.0M+55.9%	$143.0M-26.1%	$193.4M-2.6%	$198.6M
Net Income	$1.2B	$899.0M+14.7%	$784.0M+15.3%	$680.0M-25.0%	$907.0M-19.7%	$1.1B+109.5%	$539.0M-33.9%	$816.0M-7.7%	$884.0M+49.3%	$592.0M+26.2%	$469.0M+51.8%	$309.0M-22.5%	$398.5M+51.1%	$263.8M-24.5%	$349.5M+7.9%	$323.8M
EPS (Basic)	N/A	$6.01+21.4%	$4.95+13.8%	$4.35-25.0%	$5.80-14.7%	$6.80+122.2%	$3.06-30.6%	$4.41+1.1%	$4.36+60.9%	$2.71+35.5%	$2.00+66.7%	$1.20-28.6%	$1.68+6.3%	$1.58+62.9%	$0.97+16.9%	$0.83
EPS (Diluted)	$7.85	$6.01+21.4%	$4.95+13.8%	$4.35-24.9%	$5.79-14.7%	$6.79+124.8%	$3.02-27.4%	$4.16+2.0%	$4.08+56.9%	$2.60+30.7%	$1.99+65.8%	$1.20-28.6%	$1.68+6.3%	$1.58	$0.97+16.9%	$0.83
Diluted Shares (Avg)	N/A	147M0.0%	147M-0.4%	148M-1.7%	150M-6.2%	160M-3.2%	166M-11.2%	187M-9.7%	207M-1.5%	210M+2.6%	204M+0.3%	204M+5.7%	193M+4.6%	184M	183M+0.3%	183M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Revenue	$1.1B+35.7%	$849.0M+6.8%	$891.0M+8.7%	$861.0M+8.7%	$838.0M+7.9%	$795.0M+7.1%	$820.0M+12.2%	$792.0M+3.5%
SG&A Expenses	$344.0M+2.4%	$361.0M+5.6%	$546.0M+7.3%	$337.0M+6.3%	$336.0M+5.7%	$342.0M+3.3%	$509.0M-12.4%	$317.0M+1.9%
Interest Expense	$342.0M-15.1%	$334.0M-17.3%	$683.0M+8.9%	$392.0M-19.0%	$403.0M-15.3%	$404.0M-13.7%	$627.0M+7.5%	$484.0M+13.9%
Income Tax	$130.0M+91.2%	$61.0M-11.6%	N/A	$63.0M0.0%	$68.0M+11.5%	$69.0M+38.0%	N/A	$63.0M+18.9%
Net Income	$453.0M+85.7%	$233.0M+37.1%	$263.0M+21.8%	$222.0M+3.7%	$244.0M+21.4%	$170.0M+11.1%	$216.0M+71.4%	$214.0M+22.3%
EPS (Basic)	$3.05+87.1%	$1.56+38.1%	$1.76+31.3%	$1.48+8.0%	$1.63+27.3%	$1.13+17.7%	$1.34+71.8%	$1.37+21.2%
EPS (Diluted)	$3.05+87.1%	$1.56+38.1%	$1.76+31.3%	$1.48+8.0%	$1.63+27.3%	$1.13+17.7%	$1.34+71.8%	$1.37+21.2%
Diluted Shares (Avg)	146M-0.6%	147M-0.2%	N/A	147M0.0%	147M0.0%	147M0.0%	N/A	147M-0.3%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

ZIONP Balance Sheet

ZIONP quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$88.7B-0.1%	$88.8B+1.8%	$87.2B-2.6%	$89.5B-3.9%	$93.2B+14.4%	$81.5B+17.8%	$69.2B+0.6%	$68.7B+3.7%	$66.3B+4.8%	$63.2B+6.0%	$59.7B+4.3%	$57.2B+2.1%	$56.0B+0.9%	$55.5B+4.4%	$53.1B
Cash & Equivalents	$683.0M+4.9%	$651.0M-9.1%	$716.0M+9.0%	$657.0M+10.4%	$595.0M+9.6%	$543.0M-23.0%	$705.0M+14.8%	$614.0M+12.0%	$548.0M	N/A	N/A	N/A	N/A	N/A	N/A
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$1.1B+3.2%	$1.0B0.0%	$1.0B0.0%	$1.0B+1.3%	$1.0B0.0%	$1.0B0.0%	$1.0B0.0%	$1.0B0.0%	$1.0B0.0%	$1.0B0.0%	$1.0B0.0%	$1.0B0.0%	$1.0B0.0%	$1.0B-0.1%	$1.0B
Total Liabilities	$81.5B-1.4%	$82.7B+1.4%	$81.5B-3.7%	$84.7B-1.3%	$85.7B+16.5%	$73.6B+19.0%	$61.8B+1.1%	$61.2B+4.4%	$58.6B+5.4%	$55.6B+6.6%	$52.2B+4.7%	$49.8B+0.6%	$49.6B+0.2%	$49.5B+7.1%	$46.2B
Long-Term Debt	$1.5B+54.9%	$950.0M+75.3%	$542.0M-16.7%	$651.0M-35.7%	$1.0B-24.3%	$1.3B-22.5%	$1.7B+138.0%	$724.0M+89.0%	$383.0M-28.4%	$535.0M-34.1%	$812.4M-25.6%	$1.1B-52.0%	$2.3B-2.7%	$2.3B+19.6%	$2.0B
Total Equity	$7.2B+17.2%	$6.1B+7.6%	$5.7B+16.3%	$4.9B-34.4%	$7.5B-5.4%	$7.9B+7.2%	$7.4B-3.0%	$7.6B-1.3%	$7.7B+0.6%	$7.6B+1.7%	$7.5B+1.9%	$7.4B+14.0%	$6.5B+6.8%	$6.1B-13.4%	$7.0B
Retained Earnings	$7.3B+9.4%	$6.7B+7.9%	$6.2B+6.9%	$5.8B+12.3%	$5.2B+20.1%	$4.3B+7.5%	$4.0B+16.0%	$3.5B+23.1%	$2.8B+20.9%	$2.3B+18.0%	$2.0B+11.1%	$1.8B+20.1%	$1.5B+22.4%	$1.2B+16.1%	$1.0B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Total Assets	$89.0B+0.2%	$88.0B0.0%	$88.7B-0.1%	$88.5B+1.7%	$88.9B+1.5%	$88.0B+1.1%	$88.8B+1.8%	$87.0B-0.3%
Cash & Equivalents	$793.0M+1.7%	$661.0M-20.6%	$683.0M+4.9%	$771.0M-30.8%	$780.0M+8.8%	$833.0M+17.5%	$651.0M-9.1%	$1.1B+59.1%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	$1.1B+3.2%	N/A	N/A	N/A	$1.0B0.0%	N/A
Total Liabilities	$81.4B-1.1%	$80.7B-1.2%	$81.5B-1.4%	$81.7B+1.3%	$82.3B+0.9%	$81.7B+0.5%	$82.7B+1.4%	$80.6B-1.6%
Long-Term Debt	$2.0B+101.6%	$2.0B+103.6%	$1.5B+54.9%	$1.5B+168.8%	$970.0M+77.7%	$964.0M+77.2%	$950.0M+75.3%	$548.0M+1.5%
Total Equity	$7.7B+16.4%	$7.3B+15.3%	$7.2B+17.2%	$6.9B+7.5%	$6.6B+9.5%	$6.3B+8.5%	$6.1B+7.6%	$6.4B+20.1%
Retained Earnings	$7.9B+12.9%	$7.5B+10.2%	$7.3B+9.4%	$7.1B+8.7%	$7.0B+8.7%	$6.8B+8.1%	$6.7B+7.9%	$6.6B+6.6%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities.

ZIONP Cash Flow Statement

ZIONP quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$1.8B	$1.1B-6.5%	$1.1B+29.7%	$885.0M-39.8%	$1.5B+133.7%	$629.0M-12.5%	$719.0M+3.2%	$697.0M-40.7%	$1.2B+26.7%	$928.0M+55.7%	$596.0M+28.4%	$464.0M+22.0%	$380.3M-54.5%	$835.1M+13.4%	$736.2M-31.1%	$1.1B
Depreciation & Amortization	N/A	$116.0M-6.5%	$124.0M-11.4%	$140.0M+27.3%	$110.0M+885.7%	-$14.0M-116.3%	$86.0M-54.3%	$188.0M-2.6%	$193.0M+7.8%	$179.0M+45.5%	$123.0M+43.0%	$86.0M+49.1%	$57.7M-55.8%	$130.6M-29.5%	$185.2M-23.0%	$240.5M
Stock-Based Compensation	N/A	$35.0M+6.1%	$33.0M0.0%	$33.0M+10.0%	$30.0M+7.1%	$28.0M+7.7%	$26.0M-3.7%	$27.0M+3.8%	$26.0M+4.0%	$25.0M-3.8%	$26.0M+4.0%	$25.0M+5.8%	$23.6M-15.8%	$28.1M-11.0%	$31.5M+8.7%	$29.0M
Capital Expenditures	$121.0M	$121.0M+24.7%	$97.0M-14.2%	$113.0M-40.5%	$190.0M-7.8%	$206.0M+20.5%	$171.0M+46.2%	$117.0M-9.3%	$129.0M-23.7%	$169.0M-13.8%	$196.0M+24.8%	$157.0M-10.7%	$175.8M+98.5%	$88.6M+28.6%	$68.9M-11.3%	$77.7M
Free Cash Flow	$1.7B	$952.0M-9.4%	$1.1B+36.1%	$772.0M-39.7%	$1.3B+202.6%	$423.0M-22.8%	$548.0M-5.5%	$580.0M-44.6%	$1.0B+37.9%	$759.0M+89.8%	$400.0M+30.3%	$307.0M+50.1%	$204.5M-72.6%	$746.5M+11.9%	$667.3M-32.7%	$991.1M
Investing Cash Flow	-$552.0M	$738.0M+145.0%	-$1.6B-169.2%	$2.4B+68.7%	$1.4B+112.1%	-$11.6B+5.1%	-$12.2B-3354.4%	$375.0M+113.9%	-$2.7B+31.0%	-$3.9B-14.1%	-$3.4B-33.2%	-$2.6B-103.3%	-$1.3B+6.2%	-$1.4B+28.0%	-$1.9B+23.7%	-$2.5B
Financing Cash Flow	-$1.2B	-$1.8B-516.6%	$427.0M+113.4%	-$3.2B-13.6%	-$2.8B-125.6%	$11.0B-2.8%	$11.3B+1254.2%	-$981.0M-161.5%	$1.6B-43.0%	$2.8B+0.8%	$2.8B+34.2%	$2.1B+271.7%	$557.1M+470.6%	-$150.3M-108.5%	$1.8B+3.9%	$1.7B
Dividends Paid	$272.0M	$267.0M-7.6%	$289.0M+2.5%	$282.0M+4.8%	$269.0M+3.1%	$261.0M+0.8%	$259.0M-0.4%	$260.0M+10.2%	$236.0M+82.9%	$129.0M+19.4%	$108.0M0.0%	$108.0M+12.3%	$96.1M-19.7%	$119.7M-10.4%	$133.6M-14.4%	$156.1M
Share Buybacks	$152.0M	$41.0M+13.9%	$36.0M-29.4%	$51.0M-74.8%	$202.0M-74.8%	$800.0M+952.6%	$76.0M-93.1%	$1.1B+64.0%	$672.0M+109.3%	$321.0M+230.9%	$97.0M+1285.7%	$7.0M+25.2%	$5.6M	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Operating Cash Flow	$422.0M+780.6%	$423.0M+136.3%	$518.0M+0.2%	$438.0M+268.1%	-$62.0M-124.7%	$179.0M-31.4%	$517.0M+311.0%	$119.0M-61.7%
Depreciation & Amortization	$27.0M-6.9%	$30.0M+7.1%	$29.0M0.0%	$30.0M-6.3%	$29.0M-6.5%	$28.0M-12.5%	$29.0M-9.4%	$32.0M-11.1%
Stock-Based Compensation	N/A	$18.0M+5.9%	N/A	N/A	N/A	$17.0M+6.3%	N/A	N/A
Capital Expenditures	$33.0M+6.5%	$25.0M-7.4%	$38.0M+35.7%	$25.0M+13.6%	$31.0M+82.4%	$27.0M-10.0%	$28.0M-3.4%	$22.0M-29.0%
Free Cash Flow	$389.0M+518.3%	$398.0M+161.8%	$480.0M-1.8%	$413.0M+325.8%	-$93.0M-139.7%	$152.0M-34.2%	$489.0M+278.5%	$97.0M-65.4%
Investing Cash Flow	-$688.0M-9.0%	$428.0M-74.2%	-$651.0M+72.5%	$359.0M-68.3%	-$631.0M-37.2%	$1.7B+3034.0%	-$2.4B-420.6%	$1.1B+865.5%
Financing Cash Flow	$398.0M-37.8%	-$873.0M+47.3%	$45.0M-96.8%	-$806.0M+5.7%	$640.0M+194.9%	-$1.7B-416.5%	$1.4B+390.6%	-$855.0M-421.3%
Dividends Paid	$68.0M+4.6%	$68.0M+3.0%	$68.0M-8.1%	$68.0M-4.2%	$65.0M-9.7%	$66.0M-7.0%	$74.0M+4.2%	$71.0M+4.4%
Share Buybacks	$75.0M	$77.0M+87.8%	$0-100.0%	$0	$0	$41.0M+17.1%	$1.0M0.0%	$0

ZIONP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ZIONP quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Net Margin	26.6%+1.5pp	25.1%+3.2pp	21.8%-7.0pp	28.8%-10.0pp	38.8%+19.5pp	19.3%-9.4pp	28.7%-3.0pp	31.8%+9.1pp	22.7%+3.0pp	19.7%+4.8pp	14.9%-3.4pp	18.3%+5.4pp	13.0%-3.3pp	16.2%+1.9pp	14.4%
Return on Equity	12.5%-0.3pp	12.8%+0.9pp	11.9%-6.6pp	18.5%+3.4pp	15.1%+8.3pp	6.8%-4.3pp	11.1%-0.6pp	11.7%+4.0pp	7.7%+1.6pp	6.1%+2.0pp	4.1%-1.3pp	5.4%+1.3pp	4.1%-1.7pp	5.8%+1.1pp	4.6%
Return on Assets	1.0%+0.1pp	0.9%+0.1pp	0.8%-0.2pp	1.0%-0.2pp	1.2%+0.5pp	0.7%-0.5pp	1.2%-0.1pp	1.3%+0.4pp	0.9%+0.1pp	0.7%+0.2pp	0.5%-0.2pp	0.7%+0.2pp	0.5%-0.2pp	0.6%0.0pp	0.6%
Debt-to-Equity	0.200.0x	0.16+0.1x	0.100.0x	0.130.0x	0.140.0x	0.17-0.1x	0.23+0.1x	0.100.0x	0.050.0x	0.070.0x	0.110.0x	0.15-0.2x	0.350.0x	0.39+0.1x	0.28
Asset Turnover	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.030.0x	0.030.0x	0.040.0x	0.040.0x	0.040.0x	0.040.0x	0.030.0x	0.040.0x	0.040.0x	0.040.0x	0.04
FCF Margin	28.1%-5.5pp	33.6%+8.8pp	24.8%-15.8pp	40.6%+26.1pp	14.5%-5.1pp	19.6%-0.8pp	20.4%-17.2pp	37.6%+8.5pp	29.1%+12.3pp	16.8%+2.0pp	14.8%+5.4pp	9.4%-27.3pp	36.7%+5.7pp	31.0%-13.0pp	44.0%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Net Margin	39.8%+10.7pp	27.4%+6.1pp	29.5%+3.2pp	25.8%-1.2pp	29.1%+3.3pp	21.4%+0.8pp	26.3%+9.1pp	27.0%+4.1pp
Return on Equity	5.9%+2.2pp	3.2%+0.5pp	3.7%+0.1pp	3.2%-0.1pp	3.7%+0.4pp	2.7%+0.1pp	3.5%+1.3pp	3.4%+0.1pp
Return on Assets	0.5%+0.2pp	0.3%+0.1pp	0.3%+0.1pp	0.3%0.0pp	0.3%0.0pp	0.2%0.0pp	0.2%+0.1pp	0.3%+0.1pp
Debt-to-Equity	0.25+0.1x	0.27+0.1x	0.200.0x	0.21+0.1x	0.15+0.1x	0.15+0.1x	0.16+0.1x	0.090.0x
Asset Turnover	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x
FCF Margin	34.2%+45.3pp	46.9%+27.8pp	53.9%-5.8pp	48.0%+35.7pp	-11.1%-41.2pp	19.1%-12.0pp	59.6%+97.1pp	12.3%-24.3pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Zions Bancorpora ZIONP	FY2025	$3.4B	$899.0M	26.6%	N/A	35/100
First Gty Bancsh FGBIP	FY2025	$95.4M	-$56.0M	-58.7%	N/A	9/100
Huntington Bancshares Inc HBANL	FY2025	$8.2B	$2.2B	27.1%	N/A	44/100
Huntingtn Bncshr HBANM	FY2025	$8.2B	$2.2B	27.1%	N/A	44/100
Bridgewater Banc BWBBP	FY2025	$143.4M	$46.1M	32.1%	N/A	60/100
Bridge Bancorp, Inc. DCOMP	FY2025	$19.9M	$110.7M	N/A	N/A	25/100

Where Zions Bancorpora Ranks

Frequently Asked Questions

What is Zions Bancorpora's annual revenue?

Zions Bancorpora (ZIONP) reported $3.4B in total revenue for fiscal year 2025. This represents a 8.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Zions Bancorpora's revenue growing?

Zions Bancorpora (ZIONP) revenue grew by 8.1% year-over-year, from $3.1B to $3.4B in fiscal year 2025.

Is Zions Bancorpora profitable?

Yes, Zions Bancorpora (ZIONP) reported a net income of $899.0M in fiscal year 2025, with a net profit margin of 26.6%.

How much debt does Zions Bancorpora have?

As of fiscal year 2025, Zions Bancorpora (ZIONP) had $683.0M in cash and equivalents against $1.5B in long-term debt.

What is Zions Bancorpora's net profit margin?

Zions Bancorpora (ZIONP) had a net profit margin of 26.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Zions Bancorpora pay dividends?

Yes, Zions Bancorpora (ZIONP) paid $1.76 per share in dividends during fiscal year 2025.

What is Zions Bancorpora's return on equity (ROE)?

Zions Bancorpora (ZIONP) has a return on equity of 12.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Zions Bancorpora's free cash flow?

Zions Bancorpora (ZIONP) generated $952.0M in free cash flow during fiscal year 2025. This represents a -9.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Zions Bancorpora's operating cash flow?

Zions Bancorpora (ZIONP) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Zions Bancorpora's total assets?

Zions Bancorpora (ZIONP) had $88.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Zions Bancorpora's capital expenditures?

Zions Bancorpora (ZIONP) invested $121.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Zions Bancorpora buy back shares?

Yes, Zions Bancorpora (ZIONP) spent $41.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Zions Bancorpora have outstanding?

Zions Bancorpora (ZIONP) had 148M shares outstanding as of fiscal year 2025.

What is Zions Bancorpora's debt-to-equity ratio?

Zions Bancorpora (ZIONP) had a debt-to-equity ratio of 0.20 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Zions Bancorpora's return on assets (ROA)?

Zions Bancorpora (ZIONP) had a return on assets of 1.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Zions Bancorpora's Piotroski F-Score?

Zions Bancorpora (ZIONP) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Zions Bancorpora's earnings high quality?

Zions Bancorpora (ZIONP) has an earnings quality ratio of 1.19x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Zions Bancorpora?

Zions Bancorpora (ZIONP) scores 35 out of 100 on our Financial Health Score, indicating weak standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.